Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Clinical trial NCT03087019 · COMPLETED
Trial details
- NCT number
- NCT03087019
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-25
- Primary completion
- 2020-08-04
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.